Schonfeld Strategic Advisors LLC Care Dx, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 32,246 shares of CDNA stock, worth $745,527. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,246Holding current value
$745,527% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding CDNA
# of Institutions
161Shares Held
53.6MCall Options Held
60.8KPut Options Held
34.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.7MShares$132 Million0.81% of portfolio
-
Black Rock Inc. New York, NY5.29MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$101 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$90.5 Million1.02% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.58MShares$59.6 Million0.03% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.24B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...